We report a rather simple method to determine glucose concentration in serum, using isotope dilution mass spectrometry and ['3C6]glucose as internal standard. The procedure involves a single step of sample purification and the conversion of the analyte into its aldononitnle pentaacetate.
MaterIals and Methods

Materials
Reagents.
Pyridine (99.8% pure), acetic anhydride were deproteinized with 0.8 mL of acetomtrile. After centrifugation, the supernate was separated and evaporated to dryness under reduced pressure. The glucose in the residue was then converted into aldononitrile by treatment with hydroxylainine hydrochloride, 2 mg in 150 pL of pyridine, at 90#{176}C for 30 mm as already described (6). Acetylation was then carried out by adding acetic anhydride (200 giL) and heating for 30 miii at the same temperature. The derivatized samples were dried and residues were dissolved in 0.5 mL of dichloromethane for CC-MS analysis. The bracketing standards were also derivatized as described. Because the aldononitrile pentaacetate derivative was stable for at least two months at 0-4 #{176}C, we could analyze the sample over a long period without any change in the isotope ratio or loss of sensitivity resulting from sample degradation.
GC/MS conditions. The isotopic ratio of serum glucose was determined by using a This number of measurements was found to be enough to define the peak profiles and to minimi7.e the variations of the peak-height ratio between consecutive injections of the same sample. The analyses were carried out by selected ion recording, monitoring ions at miz 314 and 319 for unlabeled and labeled glucose, respectively.
The amplifiers for the two channels were intercalibrated with an accuracy higher than 1%. The gain for both channels ranged from 50 to 500 mV. The baseline was drawn manually from the beginning to the end of the peak and the peak height was measured to 0.1 mm with a caliper.
Analysis.
Extracts from four aliquots of each serum sample were derivatized and 1 pL was injected. Each sample was injected twice, a third injection being carried out if the difference in peak height ratio ( 
Results
GC-MS Data
The electron ionization mass spectra of the aldononitrile pentaacetate of the two isotopic specimens of glucose used are reported in Figure 1 . The selected ion at m/z 314 originates from the loss of C3H502 fragment; the remaining fragment from [13C6lglucose contains five 13C atoms (mJz 319). Under the described conditions glucose was well separated from the other hexoses (6, 7). The measured isotope purity of the ['3C6]glucose was >98.8 atom %.
Precision Study
Bracketing standard set precision. Two sets of bracketing calibration mixtures were prepared and tested for internal consistency. In the same day the different calibration sets were used to measure the glucose concentration in the SRM 909 human serum. Aliquots (n = 3) collected from a single vial gave a mean (± SD) value of 6.30 (± 0.02) mmolfL and 6.31 (± 0.02) mmoJJL with the two sets of standard.
The two means were not statistically different.
Within-day imprecision.
Each aliquot of the same serum (the oldest SRM 909 serum) was analyzed in 
Reproducibility Study
Three aliquots of three vials of SRM 909 serum were analyzed after about two months from the first study to determine the accuracy of the method at different times. The results are summarized in Table 2 . All values, including the old one, were within the limits of uncer- tainty given by NIST (revision December 1990).
We applied the method also to Precinorm U and Precipath U to verifr the validity of the methodology with different matrixes at different concentrations.
Results are shown in Table 2 .
Discussion
The present method to determine glucose concentration in lyophilized sera displays high precision and good accuracy despite the simple procedure for sample preparation. To achieve the criteria for a Definitive Method, we determined the variation introduced by each opera- The validity of the bracketing standards was confirmed by comparison of the glucose concentration measured with two sets of standards, which did not differ from each other (P >0.05; F-test). The between-day and within-day imprecision was determined by using one of these standard calibrator sets. Statistical analysis of the data obtained in the first experiment showed that changing the day of analysis does not contribute to the For the other commercial sera tested, the overall CV Total was slightly higher, 0.53% and 0.56% for Precinorm and Precipath, respectively (Table 2 ). For the serum with a low glucose concentration, the multifactor ANOVA pointed out a significant difference at the 95% confidence level between vials, which contributed 62% to the total variance. This high variability can be attributed to one of the three Precinorm vials, for which the glucose concentration was about 8% greater than that of the other two vials. This discrepancy between vials again probably results from a different mass of the lyophilized material in the vials; however, this could not be ascertained because we did not weigh the dry-serum content of the commercial serum vials. In contrast, the Precipath serum showed homogeneity between vials (CV = 0%), but a large contribution to the overall CV was the between-aliquot variability (85%), yielding a CV of 0.51%.
In conclusion, the described method for determination of glucose concentration in serum displays total reproducibility and accuracy that satisfy the criteria for a Definitive Method (2).
